Avalo Therapeutics, Inc. of ROCKVILLE, MD, a company, filed a Form D exempt-offering notice with the SEC on 2014-07-21. The offering totals $33.3M, of which $16.3M was reported sold. Industry: Biotechnology.
Showing 25 of 52 people.
| Name | Role | Location |
|---|---|---|
| Sol J Barer | Director | Mendham, NJ |
| Blake M Paterson | Director | Baltimore, MD |
| Magnus A Persson | Director | Baltimore, MD |
| Mayukh A Sukhatme | Director | Baltimore, MD |
| Frank A Torti | Director | Menlo Park, CA |
| Bernadine Heather Fraser | Executive Officer | Baltimore, MD |
| John F Kaiser | Executive Officer | Baltimore, MD |
| Reza F Mazhari | Executive Officer | Baltimore, MD |
| Federica F O'Brien | Executive Officer | Baltimore, MD |
| Blake M Paterson | Executive Officer | Baltimore, MD |
| Sharon F Rowland | Executive Officer | Maryland, MD |
| James F Vornov | Executive Officer | Baltimore, MD |
| John Kaiser | Executive Officer | Research Triangle Park, NC |
| Behshad Sheldon | Director | Malvern, PA |
| CHRISTOPHER SULLIVAN | Executive Officer | New York, NY |
| Eugene Bauer | Director | Redwood City, CA |
| Magnus Persson | Director | Beachwood, OH |
| June Almenoff, M.D., Ph.D. | Director | Rockville, MD |
| Mitchell Chan | Director | Rockville, MD |
| Jonathan Goldman, M.D. | Director | Rockville, MD |
| Aaron Kantoff | Director | Rockville, MD |
| Gilla Kaplan, Ph.D. | Director | Rockville, MD |
| Magnus Persson, M.D., Ph.D. | Director | Rockville, MD |
| Samantha Truex | Director | Rockville, MD |
| Garry Neil, M.D. | Director | Rockville, MD |
| Filed | Form | Offering | Sold |
|---|---|---|---|
| 2024-04-09 | D | $200.0M | $130.6M |
| 2017-05-08 | D | $5.0M | $5.0M |
| 2016-09-16 | D | $15.0M | $1.0M |
| 2013-09-06 | D | $10.0M | $6.8M |
| 2012-04-04 | D | $22.5M | $22.1M |